3,4-dihydroxyphenylethanol has been researched along with alpha-cyclodextrin in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 5 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beccari, T; Bertelli, M; Capodicasa, N; Ceccarini, MR; Codini, M; Dundar, M; Ergoren, MC; Farronato, G; Farronato, M; Kroni, D; Manara, E; Paolacci, S; Percio, M; Sanlidag, T; Tartaglia, GM; Tezzele, S | 1 |
| Anpilogov, K; Bertelli, M; Camilleri, G; Dautaj, A; Dhuli, K; Dundar, M; Ergoren, MC; Farronato, G; Farronato, M; Gunsel, IS; Manara, E; Paolacci, S; Sanlidag, T; Sayan, M; Suer, HK; Sultanoglu, N; Tartaglia, GM; Tuncel, G | 1 |
| Anpilogov, K; Bertelli, M; Camilleri, G; Capodicasa, N; Connelly, ST; Dautaj, A; Dhuli, K; Gasparetto, A; Naureen, Z; Paolacci, S | 1 |
| Beccari, T; Bertelli, M; Camilleri, G; Ceccarini, MR; Connelly, ST; Cugia, G; Dautaj, A; De Forni, D; Dhuli, K; Dundar, M; Ergoren, MC; Gunsel, IS; Kaya Suer, H; Manara, E; Paolacci, S; Poddesu, B; Sanlidag, T; Sayan, M; Sultanoglu, N; Tartaglia, GM; Tuncel, G | 1 |
| Bertelli, M; Ceccarini, MR; Coatto, M; Connelly, ST; Dautaj, A; Ergoren, MC; Farronato, G; Farronato, M; Kiani, AK; Paolacci, S; Sanlidag, T; Shree, P; Tartaglia, GM; Tripathi, D; Tripathi, P; Tripathi, YB | 1 |
5 other study(ies) available for 3,4-dihydroxyphenylethanol and alpha-cyclodextrin
| Article | Year |
|---|---|
Pilot study for the evaluation of safety profile of a potential inhibitor of SARS-CoV-2 endocytosis.
Topics: Adult; Aged; Aged, 80 and over; alpha-Cyclodextrins; Antiviral Agents; Betacoronavirus; Caco-2 Cells; Cell Culture Techniques; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Endocytosis; Female; Humans; Male; Middle Aged; Oral Sprays; Pandemics; Phenylethyl Alcohol; Pilot Projects; Pneumonia, Viral; SARS-CoV-2; Young Adult | 2020 |
A pilot study on the preventative potential of alpha-cyclodextrin and hydroxytyrosol against SARS-CoV-2 transmission.
Topics: Adult; alpha-Cyclodextrins; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cyprus; Endocytosis; Female; Humans; Male; Middle Aged; Oral Sprays; Pandemics; Phenylethyl Alcohol; Pilot Projects; Pneumonia, Viral; SARS-CoV-2; Viral Load | 2020 |
Prevention of the proliferation of oral pathogens due to prolonged mask use based on α-cyclodextrin and hydroxytyrosol mouthwash.
Topics: alpha-Cyclodextrins; Candida albicans; Halitosis; Humans; Masks; Mouth Mucosa; Mouthwashes; Neisseria; Phenylethyl Alcohol; Staphylococcus aureus; Time Factors | 2021 |
In vitro and clinical studies on the efficacy of α-cyclodextrin and hydroxytyrosol against SARS-CoV-2 infection.
Topics: Administration, Intranasal; Adult; Aged; alpha-Cyclodextrins; Animals; Anti-Infective Agents; Cell Line; Chlorocebus aethiops; COVID-19; Female; Gene Expression; Health Personnel; Humans; Male; Middle Aged; Phenylethyl Alcohol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Viral; SARS-CoV-2; Virus Internalization; Young Adult | 2021 |
Scoping review on the role and interactions of hydroxytyrosol and alpha-cyclodextrin in lipid-raft-mediated endocytosis of SARS-CoV-2 and bioinformatic molecular docking studies.
Topics: alpha-Cyclodextrins; Angiotensin-Converting Enzyme 2; Binding Sites; Computational Biology; COVID-19; Humans; Membrane Microdomains; Molecular Docking Simulation; Phenylethyl Alcohol; Protein Binding; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virus Internalization | 2021 |